Plus Therapeutics, Inc. (PSTV) — DEFA14A Filings
All DEFA14A filings from Plus Therapeutics, Inc.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
-
Plus Therapeutics Files Proxy Materials
— Aug 1, 2025 Risk: low
Plus Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on August 1, 2025. The filing relates to the company's proxy materials, which ar -
Plus Therapeutics Files Proxy Materials
— May 1, 2025 Risk: low
Plus Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on May 1, 2025. The company, formerly known as Cytori Therapeutics, Inc. and Mac -
Plus Therapeutics Files Proxy Materials
— Jul 12, 2024 Risk: low
Plus Therapeutics, Inc. (formerly Cytori Therapeutics, Inc.) filed a Definitive Additional Materials proxy statement on July 12, 2024. This filing relates to th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX